Dr. Boutrid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7373 West Ln
Stockton, CA 95210Phone+1 209-476-2000
Education & Training
University of South Florida College of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2019 - 2027
OH State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, Mahmoud Abdel-Rasoul, Cynthia Timmers
Breast Cancer Research and Treatment. 2024-12-07 - 12 citationsTTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature.Hinda Boutrid, Mahmoud Kassem, Gary Tozbikian, Evan Morgan, Julia White
Frontiers in Endocrinology. 2020-04-29 - 27 citationsIntensity‐modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinomaJames T. May, Nikhil G. Rao, Roberto D. Sabater, Hinda Boutrid, Jimmy J. Caudell
Head & Neck. 2013-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
